| 中文名称 | 萘甲唑林 |
|---|---|
| 中文别名 | 萘甲唑林;萘甲唑啉;2-(1-萘甲基)-4,5-二氢-1H-咪唑;萘甲唑啉-D4;2-(1-萘甲)咪唑啉鹽酸鹽;萘达帕汀 |
| 英文名称 | 2-(naphthalen-1-yl)methyl-4,5-dihydro-1H-imidazole |
| 英文别名 | 2-(Naphthalen-1-ylmethyl)-4,5-dihydro-1H-imidazole;Naphazoline;Antan;Clearine;Nafazolina;Naphthizine;2-(naphthalen-1-yl)methyl-4,5-dihydro-1H-imidazole;2-Imidazoline, 2-(1-naphthylmethyl)- (7CI, 8CI);4,5-Dihydro-2-(1-naphthalenylmethyl)-1H-imidazole (ACI);Naphazoline (6CI);2-(1-Naphthalenylmethyl)-2-imidazoline;2-(1-Naphthylmethyl)-2-imidazoline;2-[(Naphthalen-1-yl)methyl]-4,5-dihydro-1H-imidazole;Antigaimorit;Colirio Alfa;Euboral Oftalmico;Imidin;MeSH ID: D009278;Naphthazoline;Nephazoline;Rhinazine;CHEMBL1706;Privine (Salt/Mix);SCHEMBL34532;Naphazolinum;HMS2090D15;2-(Naphthyl-(1')-methyl)imidazolin [German];L000878;KBio2_001455;Nadaplatin;2-(1-Naphthylmethyl)-4,5-dihydro-1H-imidazole;Tox21_113645;Naphazolinum [Latin];NINDS_000456;SBI-0051454.P003;2-Naphthalen-1-ylmethyl-4,5-dihydro-1H-imidazole; hydrochloride;Prestwick2_000046;cid_11079;DivK1c_000456;S01GA01;Prestwick0_000046;BRD-K77641333-003-25-5;BRD-K77641333-003-05-7;NAPHAZOLINE [MART.];Naphazolinum (Latin);KBioSS_001455;.alpha.-Naphthylmethyl imidazoline;Spectrum5_001424;alpha-Naphthylmethyl imidazoline;Q415433;Spectrum2_001054;DB06711;Nafazolin (TN);A840596;NCGC00024349-03;2-(1-naphthylmethyl)-4,5-dihydro-1H-imidazole;Naphazoline;BRN 0151864;2-(Naphthyl-(1')-methyl)imidazolin;835-31-4;Prestwick3_000046;KBio2_004023;BSPBio_000171;NAPHAZOLINE [MI];5-23-08-00293 (Beilstein Handbook Reference);NAPHAZOLINE [INN];2-(1-Naphthylmethyl)-4,5-dihydro-1H-imidazole #;Ciba 2020/R;CAS-550-99-2;NCGC00016506-02;CS-0034952;2-(alpha-Naphthylmethyl)-imidazoline;NCGC00016506-03;NAPHAZOLINE [WHO-DD];2-Imidazoline, 2-(1-naphthylmethyl)-;Naphazolinum [INN-Latin];AKOS000295230;Naphazoline [INN:BAN];NCGC00016506-04;NAPHAZOLINE [VANDF];DTXSID3048449;Prestwick1_000046;Naphazolinum (INN-Latin);GTPL5509;VS-03410;CHEMBL761;Nafazoline;UNII-H231GF11BV;FT-0725973;10061-11-7;EINECS 212-641-5;R01AA08;Sanorin (Salt/Mix);CCG-250339;BDBM50001922;SPBio_001008;AB00053505_14;CNIIGCLFLJGOGP-UHFFFAOYSA-N;EN300-16752;Z56762888;KBio1_000456;NCGC00016506-01;KBio2_006591;2-(1-naphthalenylmethyl)-4,5-dihydro-1H-imidazole;BPBio1_000189;CAS-835-31-4;SPBio_002092;KBioGR_000595;Spectrum_000975;AB00053505-12;AB00053505_13;DTXCID90198485;NCGC00016506-05;Nafazolin;H231GF11BV;CHEBI:93363;AB00053505-11;R01AB02;Spectrum4_000068;Enamine_000333;Nafazoline [Spanish];NAPHAZOLINE (MART.);Naphazoline (INN);Tox21_113058;D08253;IDI1_000456;2-(.alpha.-Naphthylmethyl)-imidazoline;HY-111326;Spectrum3_000513;BSPBio_002065;Nafazolina [DCIT];BRD-K77641333-003-15-6;NS00003424;1H-Imidazole, 4,5-dihydro-2-(1-naphthalenylmethyl)-;KBio3_001565;HMS1394P03;4,5-Dihydro-2-(1-naphthylmethyl)imidazole;NAFAZAIR;BRD-K77641333-003-26-3;BRD-K77641333-003-27-1;DB-050155;AK-968/41090774;BBL012612;STK300042;G77792 |
| CAS No. | 835-31-4 |
| 分子式 | C14H14N2 |
| 分子量 | 210.27 |
4-(2-((2R,3R)-3-(2,5-二氟苯基)-3-羟基-4-(1H-1,2,4-三唑-1-基)丁-2-基)噻唑-4-基)苯甲腈
N-(丁基磺酰基)-O-[4-(4-哌啶基)丁基]-L-酪氨酸盐酸盐一水合物
2-(4-(1-羟基-4-(4-(羟基二苯基甲基)哌啶-1-基)丁基)苯基)-2-甲基丙酸
7-环戊基-N,N-二甲基-2-((5-(哌嗪-1-基)吡啶-2-基)氨基)-7H-吡咯并[2,3-d]嘧啶-6-甲酰胺
(1-((2R,3R,4S,5R)-3,4-二羟基-5-甲基四氢呋喃-2-基)-5-氟-2-氧代-1,2-二氢嘧啶-4-基)氨基甲酸戊酯
((3S,5R)-5-((1H-1,2,4-三唑-1-基)甲基)-5-(2,4-二氟苯基)四氢呋喃-3-基)甲基 4-甲基苯磺酸酯
N-(3-氯-4-氟苯基)-7-甲氧基-6-(3-吗啉-4-丙氧基)喹唑啉-4-胺
(6R,7R)-3-甲基-7-[(R)-2-氨基-2-苯乙酰氨基]-8-氧-5-硫杂-1-双环[4.2.0]辛-2-烯-2-甲酸
(2R,3S,5S)-3-苄氧基-5-[2-[[(4-甲氧基苯基)二苯基甲基]氨基]-6-苄氧基-9H-嘌呤-9-基]-2-苄氧基甲基环戊醇
(2R,3R,4S,5R)-2-(4-氨基吡咯并[2,1-F][1,2,4]三嗪-7-基)-3,4-二羟基-5-(羟甲基)四氢呋喃-2-甲腈
本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的,不可用于人类或动物的临床诊断或者治疗,非药用,非食用。
CopyRight @2025 广东元丰化学试剂有限公司 版权所有 | 隐私政策 条款及条件 | 粤ICP备2025403430号-1
技术支持:库价化学